A study in Healthy Female Adults to Look at the Safety and Immune Response of RSV Prefusion F (preF) Subunit Vaccine Formulated in MDV
A Phase 3, Randomized, Open-label Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine Formulated in Multidose Vials in Healthy Female Adults
Category & Conditions: Vaccine-related Conditions
Medicine: Respiratory Syncytial Virus (RSV) Multi Dose Vial (MDV)
ClinicalTrials.gov Identifier (NCT): NCT06473519
Protocol ID: C4841001
Open Plain Language Summary Result:
Click here